Expert meeting on market transparency to improve access to high-priced innovative medicines (2020)

18 February 2020, National Institute for Health and Disability Insurance, Brussels, Belgium

On 18 February 2020, the Health Technologies and Pharmaceuticals Programme within the WHO Division of Health Systems and Public Health convened a high-level informal expert meeting on the situation regarding access to innovative, high-value medicines in Europe. The aim was to propose mechanisms by which the WHO Regional Office for Europe could contribute to implementation of World Health Assembly resolution WHA72.8 in the Region. This was a preliminary event in the lead-up to a high-level meeting originally scheduled to be hosted by the Government of Norway in June 2020 (since postponed to 1–2 March 2021), which will involve the participation of representatives of Member States and stakeholders.